Product Information
BREZTRI AEROSPHERE 160-9-4.8 MCG is a brand product labeled by AstraZeneca Pharmaceuticals LP, priced at $61.3864 per GM under NDC 00310461639. Its NADAC has been published 284 times since Mar 17, 2021.
FDA first approved this application on Jul 23, 2020.
Strength
160; 4.8; 9 ug/1; ug/1; ug/1
Manufacturer
AstraZeneca Pharmaceuticals LPNDC
00310461639
Classification
Brand
Dosage Form
AEROSOL, METERED
Route
RESPIRATORY (INHALATION)
Effective Date
8/19/2026
Active Ingredients
BUDESONIDE; FORMOTEROL; GLYCOPYRROLATEApproval Type
New Drug (NDA)
FDA Application
NDA212122FDA Approved
7/23/2020
On Market Since
7/23/2020
Pharmacological Classes
Price Statistics
The NADAC for BREZTRI AEROSPHERE 160-9-4.8 MCG has been published 284 times since Mar 17, 2021, and over the history we have for it it has risen 15.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $61.3864 per GM |
|---|---|
| All-time high | $61.4495 (Jul 15, 2026) |
| All-time low | $53.1936 (Mar 17, 2021) |
| 52-week high | $61.4495 |
| 52-week low | $59.2481 |
| Median price | $56.4336 |
| Average price | $57.0242 |
| Largest weekly change | +3.0% (Jan 14, 2026) |
| Weeks tracked | 284 |
| Tracking since | Mar 17, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BREZTRI AEROSPHERE 160-9-4.8 MCG?
The current National Average Drug Acquisition Cost (NADAC) for BREZTRI AEROSPHERE 160-9-4.8 MCG, manufactured by AstraZeneca Pharmaceuticals LP, is $61.3864 per GM (NDC 00310461639), effective Aug 19, 2026.
How has the price of BREZTRI AEROSPHERE 160-9-4.8 MCG changed over time?
Over the history we have for it, the NADAC for BREZTRI AEROSPHERE 160-9-4.8 MCG has risen 15.4%. It has been tracked across 284 weekly CMS publications since Mar 17, 2021.
What are the highest and lowest recorded NADAC prices for BREZTRI AEROSPHERE 160-9-4.8 MCG?
Since Mar 17, 2021, the NADAC for BREZTRI AEROSPHERE 160-9-4.8 MCG has ranged from a low of $53.1936 (Mar 17, 2021) to a high of $61.4495 (Jul 15, 2026), with a median of $56.4336 per GM.
Are there cheaper alternatives to BREZTRI AEROSPHERE 160-9-4.8 MCG?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BREZTRI AEROSPHERE 160-9-4.8 MCG, is $61.2823 per GM — about 0% below BREZTRI AEROSPHERE 160-9-4.8 MCG.
Who manufactures BREZTRI AEROSPHERE 160-9-4.8 MCG?
BREZTRI AEROSPHERE 160-9-4.8 MCG (NDC 00310461639) is labeled by AstraZeneca Pharmaceuticals LP, and CMS classifies it as a brand product.